產(chǎn)品編號(hào) | BIO1021SM |
英文名稱 | Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig Biosimilar) |
別 名 | CTLA-4 / CD152 & PDCD1 / PD-1 / CD279; Volrustomig |
抗體來源 | |
克隆類型 | Monoclonal |
交叉反應(yīng) | Human |
產(chǎn)品應(yīng)用 |
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理論分子量 | 146.77kDa |
性 狀 | Lyophilized |
亞 型 | IgG-like |
純化方法 | Protein A |
緩 沖 液 | 100 mM Pro-Ac 20mM Arg pH 5.0 |
保存條件 | -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions;Avoid repeated freeze-thaw cycles. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產(chǎn)品介紹 | |
產(chǎn)品圖片 |
Co-incubation of Volrustomig with PD-1-NF-AT-Jurkat and CD3L-huPD-L1-CHO-K cells and incubated for 6 hours. Bright-Lite was used to detect the fluorescent signal. As shown in fig, Volrustomig was able to block the PD-1/PD-L1 signaling pathway, and the EC50 was 6.643 nM.
Volrustomig bound to huCD40-CHO-K cells, and then rebounded to fluorescent secondary antibodies(Anti-human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Volrustomig bound to huCD40-CHO-K cells, and the EC50 was 8.874 nM.
Volrustomig bound to huPD-1-Jurkat cells, and then rebounded to fluorescent secondary antibodies(Anti-human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Volrustomig bound to huPD-1-Jurkat cells, and the EC50 was 2.279 nM.
Volrustomig bound to PD-1 protein, and then rebounded to secondary antibodies(Anti-human-IgG-Fc-HRP) , and read OD450. As shown in fig, Volrustomig bound to hu-PD-1-His, and the EC50 was 0.006 nM.
Volrustomig bound to CTLA4 protein, and then rebounded to secondary antibodies(Anti-human-IgG-Fc-HRP) , and read OD450. As shown in fig, Volrustomig bound to huCTLA4-His, and the EC50 was 0.008 nM.
Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
|